• TARGET AUDIENCE

This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.

• Onsite and Remote Learning Options:

The course will be offered as a live conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.

Objectives:

An attendee completing this course should be able to:

• Provide the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, thromboembolic disease
• Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
• Apply he best considerations of percutaneous interventions for coronary heart disease
• Improve the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases
• Identify risk stratification of cardiovascular disease
• Optimize management of peripheral artery disease
• Identify and treat accordingly, the differing pathophysiology of diseases and treatment options among racial and ethnic groups
• Enhance management of COVID-19 and its cardiovascular complications

Course Outline:

Friday, December 8, 2023

•  Registration and Continental Breakfast
• Welcome and Symposium Overview Priscilla Hsue, MD

Session: Frontiers in Cardiology: Artificial Intelligence and the Heart, Updates in Pulmonary
Hypertension and Peripheral Vascular Disease- Chair: Priscilla Hsue, MD

1. Artificial Intelligence and Cardiology Debate: Sonographer vs. AI  David Ouyang, MD

2. Myocarditis: Where Are We in 2023? Bettina Heidecker, MD
3.  Genetics, Artificial Intelligence and the Heart
   James Pirruccello, MD
4.  Coffee Break
5. Pulmonary Hypertension – What is New in 2023 Marc Simon, MD
6.  Peripheral Vascular Disease Updates in 2023 Eric Secemsky, MD
7.  Elliot Rapaport Keynote Lecture: Earning Trust: The Heart of the Matter
   Julie Gerberding MD
8. Lunch (on Your Own)

• Session: New Approaches to Improving Outcomes in Heart Failure, Valve Disease, Pulmonary

  Embolism and Cardiac Arrest Chair: Lucas Zier, MD, MS

1. Interventional Approaches to Heart Failure Lucas Zier, MD, MS
2.  Improving Outcomes in Acute Pulmonary Embolism
   Antonio Gomez, MD
3.  Neuroprotection Strategies After Cardiac Arrest Claude Hemphill, MD
4. Coffee Break
5. Modern Role of the Ross Procedure in the Treatment of Aortic Valve Disease
   Marko Boskovski, MD, MHS, MPH
6. The Current State and Future Direction of Critical Care Cardiology
   Chris Barnett, MD and Connor  O’Brien, MD
7.  Adjourn

Saturday, December 9, 2023

1. Continental Breakfast
2. Announcements Priscilla Hsue, MD

• Session: Advances and Controversies in Electrophysiology Chair: Nora Goldschlager, MD

1. Debate: Older Patients with High CHADS-VASC and Bleeding Risk Should Have Left Atrial Appendage Closed
   Tommy Dewland, MD (pro)
   Adam Lee, MD (con)
2.  Pacing for Heart Failure with Preserved Ejection Fraction
   Ram Venkateswaran, MD
3. Debate: Treatment for Symptomatic Atrial Fibrillation First-line Ablation vs. Pharmacologic Therapy
   Ed Gerstenfeld, MD
   Joshua Moss MD
4. Coffee Break
5.  New Technologies in Pacing for Central Sleep Apnea and Heart Failure
   Byron Lee, MD
6.  The Effect of Alcohol, Caffeine and Tobacco on Atrial Fibrillation – Are Any Vices OK?
   Gregory Marcus, MD, MAS
7.  Lunch (on your own)

• Session: Managing Heart Failure Chair: Jonathan Davis, MD, MPHS

1. Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction
   Rose Pavlakos PharmD
2.  Remote Monitoring of Patients with Heart Failure Liviu Klein, MD, MS
3. Right Ventricular Heart Failure Brian Houston, MD
4.  Coffee Break
5. Review of Guideline for and Management of Heart Failure
   Jonathan Davis, MD, MPHS
6.  Approach to Multivessel Coronary Artery Disease in Patients with Reduced Ejection Fraction
   Amy Fiedler, MD and
   Krishan Soni, MD, MBA
7.  Adjourn

Sunday, December 10, 2023

1.  Continental Breakfast
2.  Announcements Priscilla Hsue, MD

• Session: Managing Cardiovascular Risk Chair: Peter Ganz, MD

1.  Clonal Hematopoiesis of Indeterminate Potential (CHIP): A Novel Cardiovascular Risk Factor
   Peter Libby, MD
2.  Lipid Management Beyond Statins: What, Why, and Who?
   Christie Ballantyne, MD
3.  Lp(a): Why is It Important? Michelle O’Donoghue, MD, MPH
4.  Weight Loss and Cardiovascular Risk: Current Concepts
   Sarah Kim, MD
5. Making Sense of Popular Diets: Alignment with AHA 2021 Dietary Guidance
   Christopher Gardner, PhD
6.  Adjour